Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7558629

Concept 2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
113,270,000,000 JPY
105,534,000,000 JPY
102,904,000,000 JPY
109,983,000,000 JPY
113,620,000,000 JPY
Operating revenue
5,853,000,000 JPY
6,575,000,000 JPY
7,189,000,000 JPY
7,244,000,000 JPY
8,043,000,000 JPY
Ordinary profit (loss)
2,975,000,000 JPY
5,827,000,000 JPY
3,960,000,000 JPY
5,569,000,000 JPY
4,585,000,000 JPY
6,447,000,000 JPY
4,482,000,000 JPY
8,175,000,000 JPY
5,115,000,000 JPY
9,438,000,000 JPY
Profit (loss)
3,005,000,000 JPY
3,919,000,000 JPY
4,516,000,000 JPY
4,476,000,000 JPY
5,076,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
Total number of issued shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
64,607,936 xbrli:shares
Net assets
64,935,000,000 JPY
125,461,000,000 JPY
124,507,000,000 JPY
64,952,000,000 JPY
124,661,000,000 JPY
64,812,000,000 JPY
122,710,000,000 JPY
64,642,000,000 JPY
123,395,000,000 JPY
64,525,000,000 JPY
Total assets
99,304,000,000 JPY
176,045,000,000 JPY
171,924,000,000 JPY
95,619,000,000 JPY
167,126,000,000 JPY
95,391,000,000 JPY
171,160,000,000 JPY
95,126,000,000 JPY
173,034,000,000 JPY
104,727,000,000 JPY
Net assets per share
1,118.53
2,189.40
2,172.83
1,118.83
2,175.52
1,116.42
2,142.07
1,113.61
2,154.05
1,111.61
Dividend paid per share
52
52
75
75
75
Interim dividend paid per share
20
20
30
30
30
Basic earnings (loss) per share
51.78
82.44
67.51
68.62
77.80
106.99
77.11
107.35
76.48
104.68
Diluted earnings per share
Equity-to-asset ratio
0.654 xbrli:pure
0.713 xbrli:pure
0.724 xbrli:pure
0.679 xbrli:pure
0.746 xbrli:pure
0.679 xbrli:pure
0.717 xbrli:pure
0.680 xbrli:pure
0.713 xbrli:pure
0.616 xbrli:pure
Rate of return on equity
0.046 xbrli:pure
0.038 xbrli:pure
0.060 xbrli:pure
0.032 xbrli:pure
0.070 xbrli:pure
0.050 xbrli:pure
0.069 xbrli:pure
0.050 xbrli:pure
0.060 xbrli:pure
0.048 xbrli:pure
Price-earnings ratio
32.91 xbrli:pure
20.67 xbrli:pure
26.32 xbrli:pure
25.90 xbrli:pure
24.78 xbrli:pure
18.02 xbrli:pure
28.50 xbrli:pure
20.48 xbrli:pure
28.25 xbrli:pure
20.64 xbrli:pure
Payout ratio
1.006 xbrli:pure
0.772 xbrli:pure
0.966 xbrli:pure
0.974 xbrli:pure
0.982 xbrli:pure
Net cash provided by (used in) operating activities
2,008,000,000 JPY
6,346,000,000 JPY
5,189,000,000 JPY
7,739,000,000 JPY
340,000,000 JPY
Net cash provided by (used in) investing activities
-6,275,000,000 JPY
-2,560,000,000 JPY
-4,259,000,000 JPY
-2,943,000,000 JPY
14,939,000,000 JPY
Net cash provided by (used in) financing activities
-3,363,000,000 JPY
-4,112,000,000 JPY
-4,918,000,000 JPY
-5,117,000,000 JPY
-27,315,000,000 JPY
Cash and cash equivalents
18,816,000,000 JPY
26,289,000,000 JPY
26,476,000,000 JPY
30,509,000,000 JPY
30,914,000,000 JPY
Number of employees
117 xbrli:pure
2,138 xbrli:pure
2,222 xbrli:pure
115 xbrli:pure
2,243 xbrli:pure
114 xbrli:pure
2,271 xbrli:pure
113 xbrli:pure
2,297 xbrli:pure
110 xbrli:pure
Total shareholder return
1.017 xbrli:pure
1.028 xbrli:pure
1.077 xbrli:pure
1.175 xbrli:pure
1.119 xbrli:pure
Total return on share price index
1.318 xbrli:pure
1.246 xbrli:pure
1.221 xbrli:pure
0.859 xbrli:pure
0.950 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.